key: cord-0989683-2ux95pan
authors: Han, Huan; Xie, Linlin; Liu, Rui; Yang, Jie; Liu, Fang; Wu, Kailang; Chen, Lang; Hou, Wei; Feng, Yong; Zhu, Chengliang
title: Analysis of heart injury laboratory parameters in 273 COVID‐19 patients in one hospital in Wuhan, China
date: 2020-04-15
journal: J Med Virol
DOI: 10.1002/jmv.25809
sha: 3f2d078d36ca28c6a11cada8335e86a8f97b42cf
doc_id: 989683
cord_uid: 2ux95pan

An outbreak of severe acute respiratory syndrome novel coronavirus (SARS‐CoV‐2) epidemic spreads rapidly worldwide. SARS‐CoV‐2 infection caused mildly to seriously and fatally respiratory, enteric, cardiovascular, and neurological diseases. In this study, we detected and analyzed the main laboratory indicators related to heart injury, creatine kinase isoenzyme‐MB (CK‐MB), myohemoglobin (MYO), cardiac troponin I (ultra‐TnI), and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP), in 273 patients with COVID‐19 and investigated the correlation between heart injury and severity of the disease. It was found that higher concentration in venous blood of CK‐MB, MYO, ultra‐TnI, and NT‐proBNP were associated with the severity and case fatality rate of COVID‐19. Careful monitoring of the myocardiac enzyme profiles is of great importance in reducing the complications and mortality in patients with COVID‐19.

Coronaviruses can infect a variety of livestock, poultry, and humans, in which they can cause respiratory, enteric, cardiovascular, and neurological diseases. [4] [5] [6] [7] SARS-CoV-2 appears to have greater infectivity and a lower case fatality rate (CFR) as compared with SARS and Middle East respiratory syndrome coronavirus (MERS). 8 So far, a few patients with SARS-CoV-2 have developed severe pneumonia, pulmonary edema, acute respiratory distress syndrome (ARDS), or multiple organ failure and died. According to a summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention, the overall CFR was 2.3% (1023 deaths among 44 672 confirmed cases). 9 No deaths were reported among mild and severe cases.

The CFR was 49.0% among critical cases. CFR was elevated among those with pre-existing comorbid conditions, 10.5% for cardiovascular disease, 7.3% for diabetes, 6.3% for chronic respiratory disease, 6.0% for hypertension, and 5.6% for cancer. Therefore, to lower the CFR in patients with COVID-19, much attention have to be paid on heart injury and its clinical performance.

At present, information regarding the clinical features of pneumonia caused by SARS-CoV-2 is scarce. 3, 10, 11 In this study, we analyzed the main laboratory indicators of heart injury in patients with COVID-19 and investigated the correlation between heart injury and severity of the disease. 

We collected data of the first detection of heart injury laboratory parameters in these 273 patients with COVID-19 on admission.

All patients were collected 3 mL of venous blood into procoagulant tubes and EDTA-K2 anticoagulant tubes respectively in the early morning, then centrifuged at 3000 rpm for 10 minutes to separate serum and plasma. The levels of creatine kinase isoenzyme-MB (CK-MB), myohemoglobin (MYO), cardiac troponin I (ultra-TnI) in the serum were measured using standard assay kit and Siemens ADVIA CENTAUR XP automatic chemiluminescence immunoassay analyzer, and the level of N-terminal pro-brain natriuretic peptide (NT-proBNP) in the plasma was measured by the CobasE601 immunoanalyzer for all patients according to the manufacturer's instructions.

SPSS 25.0 was used for statistical analysis. Measurement data were expressed as P50 (P25~P75). Count data were analyzed by the χ 2 test or Fisher exact probability method. The measurement data are compared by the Kruskal-Wallis test. Differences between groups were analyzed. P < .05 was considered statistically significant.

A total of 273 patients with COVID-19 on admission from January 1 to February 18, 2020 were included in this study.

According to the relevant diagnostic criteria, patients were divided into three groups: mild (198 cases), severe (60 cases), and critical (15 cases). There was no significant difference in gender and age among three groups in this study ( Table 1) Next, the changes of these indicators of the three groups were compared and analyzed, as well as their relationship with the clinical classification of the disease, as shown in Figure 1 and Table 2 . The positive rate of CK-MB had no difference between the mild, severe, and critical groups. While the positive rate of MYO, ultra-TnI, and NT-proBNP is higher in severe cases and critical cases as compared with mild cases, the differences among the groups were statistically significant (P < .05). After a pairwise comparison by Bonferroni correction, it was observed that the levels of NT-proBNP and MYO were significant increased in severe cases and critical cases compared with mild cases (P < .0167), but no difference between severe cases and critical cases (P > .0167). The increase of ultra-TnI only showed a significant difference between the mild cases and severe cases (P < .0167), while there was no difference between mild and critical cases and severe and critical cases (P > .0167). Thus, the increased concentration in venous blood of MYO, ultra-TnI, and NT-proBNP were associated with the severity of COVID-19. Then, we analyzed these four heart injury parameters between the death (n = 24) and alive (246 recovered and 3 still in hospital at severe situation). All four parameters were significantly higher in the death than in the alive group (P < .001) ( Figure 2 ).

Viral pathogenicity is a well-known risk factor in chronic cardiovascular disease, a general consequence of the imbalance be- infarction, and rapid-onset heart failure. 14, 15 Since the emergence of 2019 nCoV, numerous studies have been carried out on the clinical features of the disease. 16 In a recent case report on 138 hospitalized patients with COVID-19, 7.2% developed acute cardiac injury. 11 In this study, we confirmed the heart injury association with SARS-CoV-2 infection and analyzed the correlation between heart injury and severity of COVID-19.

We divided the patients into three groups: mild, severe, and critical, according to the relevant diagnostic criteria, and de- The much higher CFR in the abnormal parameters group than in the normal parameters group indicated a higher fatality risk associated with abnormal myocardial parameters. However, the CFR in this study is higher than the CFR in others' reports, which might due to the irregular period in early February when there was a shortage of medical services for the dramatically increased infection cases.

In conclusion, the higher concentration in venous blood of CK-MB, MYO, ultra-TnI, and NT-proBNP were associated with the severity and CFR of COVID-19. Therefore, careful monitoring of the myocardiac enzyme profiles is of great importance in reducing the complications and mortality in patients with COVID-19. Normal parameters were defined as CK-MB in the range of 0-5 ng/mL; MYO, 0-110 μg/L; ultra-TnI, 0-0.04 ng/mL; NT-proBNP, 0-900 pg/mL. c Abnormal parameters were defined as parameters above the normal range.

F I G U R E 2 Levels of CK-MB, MYO, ultra-TnI, and NT-proBNP were compared and analyzed between death and alive patients with COVID-19. Till 23 March, 24 patients died among 273 cases. Two hundred forty-six recovered and 3 still in hospital at severe situation (249 alive in total). CK-MB, creatine kinase isoenzyme-MB; MYO, myohemoglobin; NT-proBNP, N-terminal pro-brain natriuretic peptide; COVID, coronavirus disease. ***P < .001

Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-the latest 2019 novel coronavirus outbreak in Wuhan, China

A novel coronavirus from patients with pneumonia in China

SARS and other coronaviruses as causes of pneumonia

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

Coronavirus pathogenesis

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in

Of birds and men: cardiologists' role in influenza pandemics

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus

novel coronavirus patients' clinical characteristics, discharge rate and fatality rate of metaanalysis

Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan

The authors declare that there are no conflict of interests.

YF and LC conceived and designed this investigation. LC and WH helped to design the scheme of the investigation. HH and RL collected the original data. LX analyzed the data. JY, FL, and KW contributed to the interpretation of the data. LX, YF, and LC contributed to the writing of the paper. HH and LX contributed equally to this study.

http://orcid.org/0000-0003-1590-0186